Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Insulin sensitizers for the treatment of non-alcoholic fatty liver disease.

Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. World J Hepatol. 2014 Apr 27; 6(4):199-206.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.